How to Buy Personalis Stock
Personalis Inc
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs.
Personalis stock last closed at $2.13, down 1.84% from the previous day, and has decreased 50.92% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.46 percentage points. Personalis stock is currently +23.12% from its 52-week low of $1.73, and -61.79% from its 52-week high of $5.58.
As of Jun 8, 2023, there are 46.78M PSNL shares outstanding. The market cap of PSNL is $99.65M. In the last 24 hours, 224,530 PSNL shares were traded.
How to Buy Personalis Stock
Wondering how to invest in Personalis stock? Here's how.
- Decide where to buy Personalis stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you decide where to buy Personalis stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Pick your method of payment and add your information.
- Evaluate Personalis stock: The Personalis ticker symbol is PSNL. Is Personalis stock a good investment? Should you buy shares of PSNL? How do PSNL's underlying business fundamentals look? Do top analysts think Personalis is a good buy? Why has PSNL's stock price moved recently? (Hint: Our stock research tools can help you evaluate if PSNL is a good stock to buy).
- Place your PSNL buy order: Decide if you will purchase PSNL shares at the current market price or use a limit order to buy PSNL shares at a specific price.
- Keep an eye on your PSNL investment: Create a watchlist to important notifications about your investment in Personalis shares.
Step 1: Decide where to buy Personalis stock
You will need a brokerage account in order to access the NASDAQ market and buy PSNL stock.
Our recommended brokerage: eToro
We believe that eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Healthcare, New York to Tokyo — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro today.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal information so you are able to invest in PSNL stock today.
How to Start a New Investment Account on eToro
- Click here to get started.
- Enter your personal data to start a new trading account.
- Send your info by hitting the "Create Account" button.
Step 3: Put funds into your brokerage account
Now that you've finished signing up on apps for stocks, you need to deposit funds:
Watch this video walkthrough if you need help depositing funds into your new investment account.
Step 4: Evaluate Personalis stock
Once you have chosen the best place to buy Personalis stock, it's absolutely critical to analyze their stock prior to buying, so you can wrap your head around the risk and opportunity.
Overview of key PSNL info
Personalis Due Diligence Checks
WallStreetZen was built to help part-time investors do better fundamental analysis in less time.
You can see all of the due diligence checks on PSNL's stock page.
What is the fair value of PSNL stock?
Analysts use many financial metrics, analyses, models, and charts to gauge PSNL's fair value.
Using relative valuations ratios:
- PSNL could be undervalued based on its P/B ratio of 0.51x, relative to Diagnostics & Research industry P/B ratio of 4x
You can do more valuation research on PSNL's stock here.
PSNL Financial Health Summary
Passed Health Checks:
- There are more short-term assets than long-term liabilities on the PSNL balance sheet.
- PSNL has cash burn of 119661000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the PSNL balance sheet.
Failed Health Checks:
- PSNL profit margin has gone down from -101.5% to -165.6% in the past year.
- PSNL has a relatively high debt to equity ratio of 0.41.
- PSNL has $148.94M in cash and short term investments. This is not sufficient to cover its annual cash burn of $119.66M.
Is it a good time to buy Personalis stock, according to analysts?
Out of 3 Equities analysts who give recommendations on PSNL, the consensus analyst rating on PSNL is a Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
Latest PSNL Analyst Recommendations
Swayampakula Ramakanth, a bottom 9% analyst from HC Wainwright & Co. reiterates PSNL with a buy rating and maintains their PSNL price target from $10.00 to $10.00, on May 4, 2023.
Mike Matson, a bottom 1% analyst from Needham maintains PSNL with a buy rating and lowers their PSNL price target from $8.00 to $7.00, on May 4, 2023.
Tejas Savant, a bottom 7% analyst from Morgan Stanley maintains PSNL with a hold rating and lowers their PSNL price target from $11.00 to $5.00, on Feb 27, 2023.
You can dig deeper into what analysts are projecting on the Personalis stock forecast page.
Metrics for Advanced PSNL Traders
PSNL Earnings
Last year, PSNL revenue was $68.68M. During the last 4 year, PSNL's revenue has grown by 9.55% per year. This was slower than the Diagnostics & Research industry average of 15.19%.
You can analyze PSNL's earnings and revenue performance here.
What are PSNL insiders up to?
Over the past year, executives and large shareholders at PSNL have sold more shares than they have bought.
Richard Chen, Chief Medical Officer and EVP of PSNL, was the latest PSNL insider to sell. They sold $1,922.58 worth of PSNL shares on May 17, 2023.
Research more about who owns PSNL shares here.
Can I get consistent income from PSNL stock?
No, Personalis doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your PSNL buy order
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a given price, place a limit order.
Hit the Open Trade button and eToro will execute the order.
If you need additional assistance buying stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your PSNL investment
Now that you own some PSNL shares, you'll want to keep up with your stock purchase.
Start a watchlist to monitor your PSNL stock.
PSNL Feed
How to Buy Stock in Personalis
To reiterate, here are the 6 steps you need to take to buy Personalis stock right now:
- Decide where to buy Personalis stock
- Sign up for a brokerage account
- Put funds into your brokerage account
- Evaluate Personalis stock
- Place your PSNL buy order
- Keep an eye on your PSNL investment
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep track of your investment in Personalis, click below.
Other Content You May Find Useful
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.